| 1 |
35281975 | The Effects of Clofibrate on Neonatal Jaundice: A Systematic Review. | 2022 |
1 |
| 2 |
35444014 | FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression. | 2022 Apr 20 |
2 |
| 3 |
35477852 | In silico screening and analysis of single-nucleotide polymorphic variants of the ABCC2 gene affecting Dubin-Johnson syndrome. | 2022 Apr 25 |
5 |
| 4 |
33534365 | Dubin-Johnson Syndrome as Differential Diagnosis for Neonatal Cholestasis. | 2021 May 1 |
2 |
| 5 |
34272713 | Case Study 6: Deconvoluting Hyperbilirubinemia-Differentiating Between Hepatotoxicity and Reversible Inhibition of UGT1A1, MRP2, or OATP1B1 in Drug Development. | 2021 |
1 |
| 6 |
34604277 | Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations: A Narrative Review. | 2021 |
1 |
| 7 |
31888882 | Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers. | 2020 Mar |
1 |
| 8 |
32796590 | Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing. | 2020 Aug 11 |
2 |
| 9 |
27676153 | Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis. | 2016 Oct 17 |
1 |
| 10 |
25315738 | Gene replacement therapy for genetic hepatocellular jaundice. | 2015 Jun |
2 |
| 11 |
26212029 | Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis. | 2015 Dec |
2 |
| 12 |
26292095 | Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells. | 2015 |
2 |
| 13 |
24459177 | The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. | 2014 Apr |
4 |
| 14 |
24523126 | Case study 5. Deconvoluting hyperbilirubinemia: differentiating between hepatotoxicity and reversible inhibition of UGT1A1, MRP2, or OATP1B1 in drug development. | 2014 |
1 |
| 15 |
24732756 | Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort. | 2014 |
1 |
| 16 |
25196354 | Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury. | 2014 |
2 |
| 17 |
25204339 | Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in hepatitis C virus patients. | 2014 Nov |
1 |
| 18 |
25336012 | Neonatal Dubin-Johnson syndrome: novel compound heterozygous mutation in the ABCC2 gene. | 2014 Oct |
2 |
| 19 |
29764065 | Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients. | 2014 May |
1 |
| 20 |
23695864 | Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. | 2013 Aug |
1 |
| 21 |
24138031 | Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs. | 2013 Mar |
3 |
| 22 |
22245901 | 4-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentration. | 2012 May |
3 |
| 23 |
22917771 | Generation and characterization of a novel multidrug resistance protein 2 humanized mouse line. | 2012 Nov |
1 |
| 24 |
23065530 | Novel mutations in the Dubin-Johnson syndrome gene ABCC2/MRP2 and associated biochemical changes. | 2012 Nov |
2 |
| 25 |
21813008 | Hepatic expression of multidrug resistance protein 2 in biliary atresia. | 2011 Aug 3 |
5 |
| 26 |
19566819 | Multidrug resistance-associated proteins and implications in drug development. | 2010 Jan |
1 |
| 27 |
20082599 | ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. | 2010 Aug |
2 |
| 28 |
19881259 | Novel large-scale deletion (whole exon 7) in the ABCC2 gene in a patient with the Dubin-Johnson syndrome. | 2009 |
1 |
| 29 |
16847695 | The apical conjugate efflux pump ABCC2 (MRP2). | 2007 Feb |
2 |
| 30 |
17517076 | Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis. | 2007 Aug |
1 |
| 31 |
16918320 | Multidrug transporters as drug targets. | 2006 Aug |
1 |
| 32 |
16952291 | Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. | 2006 Oct |
2 |
| 33 |
15795103 | Physiological, pharmacological and clinical features of the multidrug resistance protein 2. | 2005 Apr |
1 |
| 34 |
15846474 | Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene. | 2005 Apr |
1 |
| 35 |
15965653 | Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. | 2005 Sep |
2 |
| 36 |
16012956 | Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome. | 2005 Jul |
2 |
| 37 |
16080518 | Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin. | 2005 Jul-Aug |
4 |
| 38 |
16211250 | Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transport. | 2005 Nov |
1 |
| 39 |
16344598 | Carbon monoxide as a guardian against hepatobiliary dysfunction. | 2005 Nov |
1 |
| 40 |
15519273 | Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. | 2004 Oct |
1 |
| 41 |
12388433 | Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate. | 2003 Jan |
1 |
| 42 |
12524417 | Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). | 2003 Feb |
1 |
| 43 |
14692715 | The role of hepatic Mrp2 in the interaction of flavopiridol and bilirubin: impact on therapy. | 2003 Dec |
1 |
| 44 |
14705859 | Pathophysiological factors affecting CAR gene expression. | 2003 Nov |
1 |
| 45 |
11897625 | Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. | 2002 Apr |
1 |
| 46 |
12084558 | Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. | 2002 May |
3 |
| 47 |
12206135 | The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. | 2002 |
2 |
| 48 |
10944550 | A family of drug transporters: the multidrug resistance-associated proteins. | 2000 Aug 16 |
2 |
| 49 |
11023036 | Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. | 2000 |
4 |
| 50 |
11076395 | Hepatic secretion of conjugated drugs and endogenous substances. | 2000 |
1 |